InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 13.3 CNY -7.06% Market Closed
Market Cap: 11.2B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

Income Statement

Earnings Waterfall
InnoCare Pharma Ltd

Revenue
625.4m CNY
Cost of Revenue
-143.4m CNY
Gross Profit
482m CNY
Operating Expenses
-1.2B CNY
Operating Income
-730.9m CNY
Other Expenses
-155.7m CNY
Net Income
-886.6m CNY

Income Statement
InnoCare Pharma Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2020 Dec-2021 Dec-2022
Revenue
Revenue
1
N/A
1 043
+76 390%
625
-40%
Gross Profit
Cost of Revenue
0
(66)
(143)
Gross Profit
1
N/A
977
+71 574%
482
-51%
Operating Income
Operating Expenses
(496)
(1 143)
(1 213)
Selling, General & Administrative
(152)
(430)
(602)
Research & Development
(392)
(700)
(596)
Depreciation & Amortization
(39)
(42)
(71)
Other Operating Expenses
88
29
56
Operating Income
(494)
N/A
(166)
+66%
(731)
-341%
Pre-Tax Income
Interest Income Expense
104
144
(162)
Non-Reccuring Items
0
(0)
0
Total Other Income
(1)
1
(1)
Pre-Tax Income
(392)
N/A
(20)
+95%
(894)
-4 342%
Net Income
Tax Provision
0
(47)
0
Income from Continuing Operations
(392)
(67)
(894)
Income to Minority Interest
0
2
7
Net Income (Common)
(391)
N/A
(65)
+84%
(887)
-1 274%
EPS (Diluted)
-0.22
N/A
-0.04
+82%
-0.6
-1 400%

See Also

Discover More